| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-09 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-07 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |